Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | CASP1 | P29466 | 1/20 | 0.53 |
| ▸ | HBB | P68871 | 1/20 | 0.53 |
| ▸ | INSR | P06213 | 2/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.47 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.47 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.47 |
| ▸ | KDM4A | O75164 | 4/20 | 0.46 |
| ▸ | KDM2A | Q9Y2K7 | 4/20 | 0.46 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.44 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.41 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9804611 | 1.00 | NPC1 (0.53) | NPC1RAB9AMAPTSMN1; SMN2MEN1 | |
| SCHEMBL8811321 | 1.00 | NPC1 (0.53) | NPC1RAB9AMAPTSMN1; SMN2MEN1 | |
| SCHEMBL8812511 | 1.00 | NPC1 (0.53) | NPC1RAB9AMAPTSMN1; SMN2MEN1 | |
| SCHEMBL10340969 | 1.00 | NPC1 (0.53) | NPC1RAB9AMAPTSMN1; SMN2MEN1 | |
| SCHEMBL10340938 | 1.00 | NPC1 (0.53) | NPC1RAB9AMAPTSMN1; SMN2MEN1 | |
| SCHEMBL8811324 | 1.00 | NPC1 (0.53) | NPC1RAB9AMAPTSMN1; SMN2MEN1 | |
| SCHEMBL10340968 | 1.00 | NPC1 (0.53) | NPC1RAB9AMAPTSMN1; SMN2MEN1 | |
| SCHEMBL8812843 | 1.00 | NPC1 (0.53) | NPC1RAB9AMAPTSMN1; SMN2MEN1 | |
| SCHEMBL8812516 | 1.00 | NPC1 (0.53) | NPC1RAB9AMAPTSMN1; SMN2MEN1 | |
| Bromide SCHEMBL29819504 | 0.97 | NPC1 (0.53) | NPC1RAB9AMAPTSMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4455668-A2 | LUCIFERASE-BASED THERMAL SHIFT ASSAYS | Promega Corporation (US) | 2024-10-30 | — | — | EP | disclosed |
| EP-3254113-B1 | LUCIFERASE-BASED THERMAL SHIFT ASSAYS | PROMEGA CORP (US) | 2024-10-09 | — | — | EP | disclosed |
| US-11899021-B2 | Luciferase-based thermal shift assays | PROMEGA CORPORATION (US) | 2024-02-13 | — | — | US | disclosed |
| US-20230341410-A1 | LUCIFERASE-BASED THERMAL SHIFT ASSAYS | PROMEGA CORPORATION | 2023-10-26 | — | — | US | disclosed |
| US-20230341410-A1 | LUCIFERASE-BASED THERMAL SHIFT ASSAYS | PROMEGA CORPORATION | 2023-10-26 | — | — | US | disclosed |
| US-20210080470-A1 | LUCIFERASE-BASED THERMAL SHIFT ASSAYS | PROMEGA CORPORATION | 2021-03-18 | — | — | US | disclosed |
| US-10928400-B2 | Luciferase-based thermal shift assays | PROMEGA CORPORATION (US) | 2021-02-23 | — | — | US | disclosed |
| US-20200174012-A1 | LUCIFERASE-BASED THERMAL SHIFT ASSAYS | PROMEGA CORPORATION | 2020-06-04 | — | — | US | disclosed |
| US-10571471-B2 | Luciferase-based thermal shift assays | PROMEGA CORPORATION (US) | 2020-02-25 | — | — | US | disclosed |
| US-20160282360-A1 | LUCIFERASE-BASED THERMAL SHIFT ASSAYS | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2016-09-29 | — | — | US | disclosed |
| US-20160282360-A1 | LUCIFERASE-BASED THERMAL SHIFT ASSAYS | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2016-09-29 | — | — | US | disclosed |
| WO-2016127100-A1 | LUCIFERASE-BASED THERMAL SHIFT ASSAYS | PROMEGA CORPORATION (US) | 2016-08-11 | — | — | WO | disclosed |
| WO-1997002246-A1 | (AMINOSTYRYL)PYRIDINIUM COMPOUNDS FOR RADIOLABELLING CELL MEMBRANES | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1997-01-23 | — | — | WO | disclosed |